




It is known that proton pump inhibitors (PPIs) may interfere 
with calcium absorption by inducing hypochlorhydria. They 
also appear to reduce bone resorption by inhibiting osteoclastic 
vacuolar proton pumps.
The authors of this paper in the Journal of the American Medical 
Association looked at any association between PPI therapy and 
the risk of hip fracture. They used a case-control study using 
the General Practice Research Database (1987 - 2003), which 
contains information on patients in the UK. The cohort studied 
were people aged 50 and older who did and did not use PPI 
therapy. All patients who suffered a hip fracture were recorded. 
There were 13 556 hip fracture cases and 135 386 controls. The 
risk of hip fracture was significantly increased among patients 
who were prescribed long-term high-dose PPIs. The longer PPIs 
were taken, the greater the risk of hip fracture.
My mother recently suggested peppermint for indigestion. 
Perhaps she is right.
Yu-Xiao Y et al. JAMA 2006; 296: 2947-2953.
Pandemic flu mortality: how many will 
die?
There is currently a high level of interest in avian flu, both the 
epidemic in birds and in the relatively small number of human 
cases around the world. Media coverage is high, the public are 
concerned and governments are debating policy. Governments 
and donor agencies have pledged very large amounts of money 
to fight the spread of avian flu – $3.8 billion by the USA and 
AUD$555 million by Australia alone. These amounts may 
seem unreasonably large given all the current acute medical 
problems in the world, but people are spurred on by estimates 
of mortality ranging from 2 million to even up to 1 billion if 
avian flu were to become pandemic. 
But what is a reasonable estimate? Christopher Murray, from 
the Harvard Initiative for Global Health, and colleagues are 
attempting to provide a rational analysis. As they point out, 
various models of the effect of flu pandemics on mortality have 
been developed. The models make strong assumptions about 
attack rates and case fatality rates in flu cases. But, regardless 
of what assumptions underly the models, it is the 3 pandemics 
of the 20th century that are the main source of evidence for the 
potential number of people affected in the next pandemic – in 
1918 - 1920, 1957 - 1958 and 1968 - 1970. Of course it is the 1918 
- 1920 Spanish flu pandemic that caused the greatest mortality 
and which is the one that is most often used to set the upper 
limits on the potential number of deaths in the next pandemic. 
Estimates of deaths in this pandemic range from 20 million to 
100 million. 
In this paper, the authors aim to assess the vital registration 
data from the 1918 - 1920 pandemic because this was the 
largest of the 3 and also provides a clearly identifiable effect 
on mortality. The effects are calculated for a pandemic in 
2004, which is the most recent year for which per-head gross 
domestic product in international dollars is available. 
Their estimates are that, if a strain of flu were to emerge in 
2004 that was similar to the one that caused the 1918 - 1920 
pandemic, between 51 and 81 million individuals would die. 
Their results also suggest that deaths would be concentrated 
in the age groups 0 - 14, 15 - 19 and 30 - 44. They also estimate 
that 96% of these deaths would occur in the developing world. 
If this mortality were concentrated in a single year, it would 
increase global mortality by 114%. 
However, the authors question the assumption that is usually 
made that it is the 1918 - 1920 pandemic data that would set the 
upper limit on mortality from any future flu pandemic. They 
point out that there is no logical or biological reason why this 
pandemic should represent the maximum possible mortality 
in a future pandemic. They point out that random genetic 
mutation could produce a more lethal virus. There is also the 
uncertainty about whether the low older adult mortality in the 
1918 - 1920 pandemic was produced by acquired immunity 
from the pandemics of the mid-19th century. They also question 
the assumption that increased travel and mixing could lead to 
larger epidemics, because historical records show that nearly all 
human populations were eventually exposed to the 1918 - 1920 
flu virus.
Fears of massive mortality are very real but, as the authors 
point out, today there are many reasons to think that a similar 
pandemic flu strain may not cause similar mortality to that of 
the 1918 - 1920 strain. First, symptomatic medical management 
is much better today, although this would probably only benefit 
individuals who have access to high-end medical care – either 
in high- to middle-income countries or in high-income sections 
of poorer countries. In the developing world, public health 
systems would be overwhelmed. Second, access to anti-flu 
drugs may have a positive effect, but this cannot be quantified, 
because these drugs have not yet been used in this situation. 
Thirdly, vaccination with a lag of 4 - 6 months from the onset 
of a pandemic could reach a large fraction of high-income 
populations. The speed of the pandemic will determine the 
potential benefit of vaccination. However, restricted vaccine 
production capacity and reality of health system coverage 
suggest that vaccination would have little or not effect on the 
poorest populations.
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Quarantine measures may also be successful, if strictly 
implemented and combined with prophylaxis. Strict quarantine 
in American Samoa seems to have avoided the 1918 - 1920 
pandemic and quarantine efforts in Australia appear to have 
delayed, but not avoided, the pandemic. 
Fourth, in 1918 - 1920, a large number of deaths were 
caused by secondary bacterial pneumonia after primary viral 
pneumonitis. Now, antibiotics for pneumonia would make 
a very real difference to case-fatality rates. This would be 
particularly true in middle- and low-income settings, where 
access to affordable antibiotics would be the most cost-effective 
strategy to prevent excess mortality. But, the conclusion is 
still that it is the countries and regions that can least afford 
to prepare for a pandemic that will be affected the most. This 
presents these countries with a policy dilemma – when they can 
scarcely afford to deal with their current health problems what 
justification is there for spending scarce resources on preparing 
for such an uncertain threat? The suggestion is that focusing 
on practical and affordable strategies for low-income countries 
would be prudent, given that this is where the biggest threat 
lies. The developed world’s record of putting resources into 
developing world health problems doesn’t suggest that this 
focus will be forthcoming.
Murray CJL et al. Lancet 2006; 368: 2211-2218.
Bridget Farham
Mark Elliott (1959 – 2006)
I knew Mark for the last 4 years of his life – a life as rich in 
experience as in its refined complexity. On 6 February 2006, six 
months to the day of being diagnosed with pancreatic cancer, 
Mark died.  In his inimitable style, Mark broke the news of the 
cancer to me in a perfunctory, yet exquisitely composed SMS. 
I met with him a few days later. Mark was in good spirits as 
he spoke, eloquently as ever, of his fate: a fate he had clearly 
accepted with equanimity. I will remember the warmth of that 
August afternoon forever. 
Mark Elliot was born on 4 March 1959 in Johannesburg. He 
grew up in Natal, where he completed his schooling at Thomas 
More College. He studied medicine at the University of the 
Free State and took up general practice in Bulwer, Melmoth and 
Pretoria. 
I came to know Mark in 2002, when he joined the Forensic 
Unit at Sterkfontein Hospital, Krugersdorp, as a medical officer. 
I immediately realised Mark was no ordinary doctor: here was a 
post-modern doctor of the old school.  His caring and empathy 
were no mere clinical aids; they represented his very nature, his 
kind – in the true sense.  State patients revered him.  His bedside 
manner was faultless; his clinical presentations succinct, 
delightful, sometimes funny, always respectful. 
Mark’s gift for language allowed him to weave words like 
‘ruse’ and ‘ribald’ into his descriptions of mental state.  It 
was therefore not surprising to discover that Mark was an 
accomplished poet. Two extracts from his poem Antigravity 
illustrate how his art buttressed him during those last days:
‘They had become less common now:
Minutes to moments
Antigravity of the soul…
Mercurial minutes
Slipping away, gently
Through the fingers of my mind.’ 
Mark readily assimilated psychiatry’s apparently arcane 
subtleties. Expanding on the literary theme, he researched the 
topic of deceit and illness-endorsing behaviour, presenting his 
integrated view in a talk entitled ‘Was Hamlet a malingerer?’. 
Mark read widely and could speak with unaffected authority 
about God, the pineal, mouse, man, machine and Mozart. 
In colleagues, friends and patients, I could see his love; in 
his parents, its origins; in his siblings, its likeness and in his 
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